In our previous pan-cancer study, glioblastoma multiforme (GBM) and liver hepatocellular carcinoma (LIHC) with high ALT levels had improved prognosis, whereas GBM with low ALT levels exhibited highly regulated expression of antigen-presenting cell-related genes [2]. This evidence concerns the gene GPT and glioblastoma.